Crinetics shareholders re-elect directors, ratify auditor, approve NEO pay

Crinetics Pharmaceuticals, Inc.

Dr. Camille Bedrosian elected with 50.8M votes for (77%), 14.9M withheld; Dr. Wendell Wierenga with 50.3M for (76%).
Ratified BDO USA as independent auditor for FY 2024: 68.0M for, 0.1M against, 16.0K abstain.
Advisory vote on named executive officer compensation approved: 64.1M for, 1.7M against, 6.0K abstain, 2.3M broker non-votes.
Approximately 78.7M shares (86% of eligible) voted at the June 7, 2024 annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.